Loading…
Loading…
ZBAO does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ZBAO and 80,000+ other tickers.
See exactly how ZBAO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ZBAO and 80,000+ other tickers.
Zhibao Technology Inc., operating through its various affiliated entities, offers online insurance brokerage services across the Chinese market. Beyond this primary activity, the company also furnishes managing general underwriter (MGU) capabilities, provides healthcare provisions, and delivers advisory services for conventional, in-person insurance brokerage. Established in 2015, the firm is headquartered in Shanghai, China.
KEY HIGHLIGHTS $154.7 Million PIPE Financing Closed: Zhibao Technology Inc. (NASDAQ: ZBAO) ("Zhibao," "we," or the "Company") has closed its previously announced private investment in public equity ("PIPE") financing for an aggregate purchase price of $154,700,000. Streamlined Unit Structure: The transaction comprises 442,000,000 PIPE Units at $0.35 per Unit (each consisting of one Class A Ordinary Share and one two-year Warrant exercisable at $0.35 per share), with 395,678,152 Units delivered at closing and the remaining 46,321,848 Units to be delivered following shareholder approval.
KEY HIGHLIGHTS Strategic Joint Venture: Zhibao Technology Inc. (NASDAQ: ZBAO) ("Zhibao," "we," or the "Company") has partnered with Dongbaohui to establish a strategic joint venture (JV) focused on driving AI-native embedded long-term insurance solutions. Exemplary Leadership: The JV will be chaired by Mr.
Shanghai, China--(Newsfile Corp. - July 31, 2026) - Zhibao Technology Inc. (NASDAQ: ZBAO) ("Zhibao," "we," or the "Company"), a leading high-growth InsurTech company and pioneer of the 2B2C digital embedded insurance model in China, today announced that it has entered into a definitive Securities Purchase Agreement (the "Agreement"), dated as of July 31, 2026, with a group of non-U.S. investors (the "Investors"). Key Highlights of the Transaction PIPE Securities Structure: Pursuant to the Agreement, the Company has agreed to issue and sell an aggregate of 442,000,000 units (each, a "PIPE Unit") to the Investors.
Shanghai, China--(Newsfile Corp. - July 22, 2026) - Zhibao Technology Inc. (NASDAQ: ZBAO) ("Zhibao," "we," or the "Company"), a leading high-growth InsurTech company and pioneer of the 2B2C digital embedded insurance model in China, today announced that it has entered into a non-binding term sheet (the "Term Sheet") with JOYERTECH AND INFORMATION OPC (the "Buyer") outlining the principal terms of a proposed private investment in public equity ("PIPE") financing (the "Transaction"). The signed term sheet is non-binding and the proposed Transaction remains subject to, among other things, the completion of satisfactory legal, financial, and operational due diligence, the negotiation and execution of definitive agreements, applicable corporate and regulatory approvals, compliance with Nasdaq listing requirements, and the satisfaction of other customary closing conditions.
Shanghai, China--(Newsfile Corp. - July 15, 2026) - Zhibao Technology Inc. (NASDAQ: ZBAO) (the "Company"), today announced that it received a written notice (the "Letter") from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with Nasdaq Rule 5550(a)(2) (the "Minimum Bid Price Requirement"), as the closing bid price for the Company's Class A ordinary shares had been below $1.00 per share for the period from May 27, 2026 to July 9, 2026. The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company's Class A ordinary shares.